Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
Croop, Robert, Goadsby, Peter J, Stock, David A, Conway, Charles M, Forshaw, Micaela, Stock, Elyse G, Coric, Vladimir, Lipton, Richard B
Published in The Lancet (British edition) (31.08.2019)
Published in The Lancet (British edition) (31.08.2019)
Get full text
Journal Article
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Lipton, Richard B, Croop, Robert, Stock, David A, Madonia, Jennifer, Forshaw, Micaela, Lovegren, Meghan, Mosher, Linda, Coric, Vladimir, Goadsby, Peter J
Published in Lancet neurology (01.03.2023)
Published in Lancet neurology (01.03.2023)
Get full text
Journal Article
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial
Croop, Robert, Madonia, Jennifer, Stock, David A., Thiry, Alexandra, Forshaw, Micaela, Murphy, Abigail, Coric, Vladimir, Lipton, Richard B.
Published in Headache (01.10.2022)
Published in Headache (01.10.2022)
Get full text
Journal Article